JP2018184448A5 - - Google Patents

Download PDF

Info

Publication number
JP2018184448A5
JP2018184448A5 JP2018139536A JP2018139536A JP2018184448A5 JP 2018184448 A5 JP2018184448 A5 JP 2018184448A5 JP 2018139536 A JP2018139536 A JP 2018139536A JP 2018139536 A JP2018139536 A JP 2018139536A JP 2018184448 A5 JP2018184448 A5 JP 2018184448A5
Authority
JP
Japan
Prior art keywords
hematopoietic stem
cells
cell
use according
progenitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2018139536A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018184448A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018184448A publication Critical patent/JP2018184448A/ja
Publication of JP2018184448A5 publication Critical patent/JP2018184448A5/ja
Withdrawn legal-status Critical Current

Links

JP2018139536A 2010-08-12 2018-07-25 改善された造血幹細胞および前駆細胞療法 Withdrawn JP2018184448A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37321210P 2010-08-12 2010-08-12
US61/373,212 2010-08-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018031941A Division JP6574279B2 (ja) 2010-08-12 2018-02-26 改善された造血幹細胞および前駆細胞療法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019197587A Division JP2020029458A (ja) 2010-08-12 2019-10-30 改善された造血幹細胞および前駆細胞療法

Publications (2)

Publication Number Publication Date
JP2018184448A JP2018184448A (ja) 2018-11-22
JP2018184448A5 true JP2018184448A5 (cg-RX-API-DMAC7.html) 2019-01-10

Family

ID=45568224

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2013524254A Expired - Fee Related JP6047489B2 (ja) 2010-08-12 2011-08-12 改善された造血幹細胞および前駆細胞療法
JP2016124416A Expired - Fee Related JP6346917B2 (ja) 2010-08-12 2016-06-23 改善された造血幹細胞および前駆細胞療法
JP2018031941A Expired - Fee Related JP6574279B2 (ja) 2010-08-12 2018-02-26 改善された造血幹細胞および前駆細胞療法
JP2018139536A Withdrawn JP2018184448A (ja) 2010-08-12 2018-07-25 改善された造血幹細胞および前駆細胞療法
JP2019197587A Withdrawn JP2020029458A (ja) 2010-08-12 2019-10-30 改善された造血幹細胞および前駆細胞療法
JP2021172986A Withdrawn JP2022009404A (ja) 2010-08-12 2021-10-22 改善された造血幹細胞および前駆細胞療法
JP2023071598A Pending JP2023109761A (ja) 2010-08-12 2023-04-25 改善された造血幹細胞および前駆細胞療法

Family Applications Before (3)

Application Number Title Priority Date Filing Date
JP2013524254A Expired - Fee Related JP6047489B2 (ja) 2010-08-12 2011-08-12 改善された造血幹細胞および前駆細胞療法
JP2016124416A Expired - Fee Related JP6346917B2 (ja) 2010-08-12 2016-06-23 改善された造血幹細胞および前駆細胞療法
JP2018031941A Expired - Fee Related JP6574279B2 (ja) 2010-08-12 2018-02-26 改善された造血幹細胞および前駆細胞療法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2019197587A Withdrawn JP2020029458A (ja) 2010-08-12 2019-10-30 改善された造血幹細胞および前駆細胞療法
JP2021172986A Withdrawn JP2022009404A (ja) 2010-08-12 2021-10-22 改善された造血幹細胞および前駆細胞療法
JP2023071598A Pending JP2023109761A (ja) 2010-08-12 2023-04-25 改善された造血幹細胞および前駆細胞療法

Country Status (9)

Country Link
US (2) US20140030232A1 (cg-RX-API-DMAC7.html)
EP (2) EP3278808A1 (cg-RX-API-DMAC7.html)
JP (7) JP6047489B2 (cg-RX-API-DMAC7.html)
CN (5) CN112516167A (cg-RX-API-DMAC7.html)
AU (1) AU2011289245B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013003366A2 (cg-RX-API-DMAC7.html)
CA (1) CA2807944C (cg-RX-API-DMAC7.html)
ES (1) ES2654994T3 (cg-RX-API-DMAC7.html)
WO (1) WO2012021845A2 (cg-RX-API-DMAC7.html)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013003366A2 (pt) * 2010-08-12 2020-08-04 Fate Therapeutics, Inc. terapia aperfeiçoada de células tronco hematopoiéticas e progenitoras
EP3785767A1 (en) 2011-12-02 2021-03-03 Fate Therapeutics, Inc. Enhanced stem cell composition
ES2682255T3 (es) 2011-12-02 2018-09-19 Fate Therapeutics, Inc. Métodos mejorados de tratamiento de isquemia
WO2014078617A1 (en) * 2012-11-16 2014-05-22 Albert Einstein College Of Medicine Of Yeshiva University Identification and use of new tumor-promoting gene in hematological malignancies
WO2014124527A1 (en) * 2013-02-18 2014-08-21 University Health Network Methods for generating hepatocytes and cholangiocytes from pluripotent stem cells
WO2014153069A2 (en) * 2013-03-14 2014-09-25 Children's Medical Center Corporation Compositions and methods for reprogramming hematopoietic stem cell lineages
US9943545B2 (en) 2013-03-15 2018-04-17 Fate Therapeutics, Inc. Stem cell culture media and methods of enhancing cell survival
EP2970913B1 (en) 2013-03-15 2018-08-22 LongBoat Explorers AB Cells, methods and apparatuses for umbilical cord blood collection and isolation of cells
WO2014150602A1 (en) * 2013-03-15 2014-09-25 Fate Therapeutics, Inc. Cell potency assay for therapeutic potential
RU2525143C1 (ru) * 2013-03-22 2014-08-10 Федеральное государственное бюджетное учреждение науки Государственный научный центр Российской Федерации-Институт медико-биологических проблем Российской академии наук СПОСОБ ЭКСПАНСИИ МОНОНУКЛЕАРНЫХ КЛЕТОК ПУПОВИННОЙ КРОВИ (пкМНК) ex vivo В ПРИСУТСТВИИ МУЛЬТИПОТЕНТНЫХ СТРОМАЛЬНЫХ МЕЗЕНХИМАЛЬНЫХ КЛЕТОК (ММСК)
US20160299148A1 (en) * 2013-11-22 2016-10-13 Washington University Biomarkers for multiple myeloma
WO2016011381A1 (en) 2014-07-18 2016-01-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Reducing cxcr4 expression and/or function to enhance engraftment of hematopoietic stem cells
CN112481211B (zh) * 2015-01-26 2024-07-05 儿童医院公司 免疫调节性提高的细胞及其使用和生产方法
JP6800859B2 (ja) 2015-01-26 2020-12-16 フェイト セラピューティクス，インコーポレイテッド 造血細胞分化を誘導するための方法および組成物
EP4249916A3 (en) * 2015-04-06 2023-11-01 President and Fellows of Harvard College Compositions and methods for non-myeloablative conditioning
EP3325612B1 (en) * 2015-07-20 2022-12-14 Angiocrine Bioscience, Inc. Methods and compositions for stem cell transplantation
JP2018520688A (ja) 2015-07-21 2018-08-02 ザ チルドレンズ メディカル センター コーポレーション Ｐｄ−ｌ１発現造血幹細胞およびその使用
EP3371314B1 (en) * 2015-11-04 2023-07-05 Fate Therapeutics, Inc. Genomic engineering of pluripotent cells
KR20250033315A (ko) 2015-11-04 2025-03-07 페이트 세러퓨틱스, 인코포레이티드 조혈 세포 분화를 유도하기 위한 방법 및 조성물
RU2628092C1 (ru) * 2016-02-10 2017-08-14 Федеральное государственное бюджетное учреждение науки Государственный научный центр Российской Федерации - Институт медико-биологических проблем Российской академии наук (ГНЦ РФ - ИМБП РАН) Способ получения МСК-ассоциированных недифференцированных гемопоэтических клеток-предшественников с фенотипов CD34+/CD133+
CN105779386B (zh) * 2016-04-06 2019-09-20 南京大学 一种间充质干细胞在制备治疗m5型白血病药物中的应用
CN105886457A (zh) * 2016-05-16 2016-08-24 中国人民解放军军事医学科学院野战输血研究所 诱导干细胞分化成外胚层祖细胞的方法
US11542473B2 (en) 2016-10-21 2023-01-03 Amniotics Ab Methods and compositions for generating hematopoietic cells
CN106754726A (zh) * 2016-12-28 2017-05-31 溯源生命科技股份有限公司 一种提高人间充质干细胞移植和归巢效率的基因治疗方法
WO2018170046A1 (en) * 2017-03-14 2018-09-20 Orig3N, Inc. Hla-indexed repository of ipscs and ipsc-derived stem cells, and related systems and methods
US11879137B2 (en) 2017-09-22 2024-01-23 The Children's Medical Center Corporation Treatment of type 1 diabetes and autoimmune diseases or disorders
EP3647413A1 (en) * 2018-10-31 2020-05-06 Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas O.A., M.P. (CIEMAT) Improvements for performing and facilitating the recovery after hematopoietic stem cell transplantation
JP2022533191A (ja) * 2019-05-17 2022-07-21 デヴェラ セラピューティクス インコーポレイテッド 拡大した幹細胞生成物を使用して、血液悪性腫瘍を有する患者の処置転帰を改善するための組成物および方法
WO2020247341A1 (en) * 2019-06-06 2020-12-10 Medeor Therapeutics, Inc. Methods of making cellular products by post-mortem mobilization and harvesting of hematopoietic cells
US12465878B2 (en) 2019-06-20 2025-11-11 Amniotics Ab Apparatus for filtering amniotic fluid
CN110585432B (zh) * 2019-08-27 2021-10-15 中国人民解放军第二军医大学 成纤维细胞生长因子受体1在制备防治肠道病毒71型感染药物中的应用
CA3154422A1 (en) 2019-10-18 2021-04-22 Jan TALTS Processes and apparatuses for obtaining amniotic mesenchymal stem cells from amniotic fluid and cells derived thereof
US20220411755A1 (en) * 2019-11-14 2022-12-29 Amgen Inc. Hematopoietic precursor cell production
CN116507346A (zh) * 2020-09-24 2023-07-28 广州辑因医疗科技有限公司 化合物用于提高人造血干细胞移植效率的用途
CN116568802A (zh) * 2020-10-30 2023-08-08 西湖生物医药科技(上海)有限公司 制备成熟红细胞的体外方法
US12435308B2 (en) 2020-11-06 2025-10-07 Amniotics Ab Immunomodulation by amniotic fluid mesenchymal stem cells
WO2024040061A2 (en) * 2022-08-16 2024-02-22 The Regents Of The University Of California Alleviating graft versus host disease using engineered inkt cells
WO2024186146A1 (ko) * 2023-03-07 2024-09-12 인제대학교 산학협력단 조혈 줄기세포 증식 또는 가동화 촉진용 조성물 및 가동화 조혈 줄기세포 수집방법

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4843155A (en) 1987-11-19 1989-06-27 Piotr Chomczynski Product and process for isolating RNA
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5635387A (en) 1990-04-23 1997-06-03 Cellpro, Inc. Methods and device for culturing human hematopoietic cells and their precursors
US5460964A (en) 1992-04-03 1995-10-24 Regents Of The University Of Minnesota Method for culturing hematopoietic cells
US5409813A (en) 1993-09-30 1995-04-25 Systemix, Inc. Method for mammalian cell separation from a mixture of cell populations
US5677136A (en) 1994-11-14 1997-10-14 Systemix, Inc. Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
US5709472A (en) * 1995-10-23 1998-01-20 Lifelines Technology, Inc. Time-temperature indicator device and method of manufacture
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
EP0880598A4 (en) 1996-01-23 2005-02-23 Affymetrix Inc RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
US5945337A (en) 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
EP1027456B1 (en) 1997-10-31 2005-03-16 Affymetrix, Inc. (a Delaware Corporation) Expression profiles in adult and fetal organs
US6020135A (en) 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
WO2000038663A2 (en) 1998-12-24 2000-07-06 Alcon Laboratories, Inc. Ep4 receptor agonists for treatment of dry eye
WO2001012596A1 (fr) 1999-08-13 2001-02-22 Taisho Pharmaceutical Co., Ltd. Derives de prostaglandine
DK1132086T3 (da) 2000-01-31 2006-08-28 Pfizer Prod Inc Anvendelse af prostaglandin (PGE2) selektive receptor 4 (EP4) agonister til behandling af akut og kronisk nyresvigt
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
FR2825261B1 (fr) 2001-06-01 2003-09-12 Maco Pharma Sa Ligne de prelevement du sang placentaire comprenant une poche de rincage
WO2003091280A1 (en) * 2002-04-26 2003-11-06 Kirin Beer Kabushiki Kaisha Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same
US6747037B1 (en) 2003-06-06 2004-06-08 Allergan, Inc. Piperidinyl prostaglandin E analogs
US20050176140A1 (en) * 2004-02-10 2005-08-11 Benedict Daniel J. Method and apparatus for cell culture using a two liquid phase bioreactor
US7147626B2 (en) 2004-09-23 2006-12-12 Celgene Corporation Cord blood and placenta collection kit
AU2005299473B2 (en) 2004-10-26 2012-06-28 Allergan, Inc. Therapeutic and delivery methods of prostaglandin EP4 agonists
DE102005062741A1 (de) 2005-12-22 2007-06-28 Bayer Schering Pharma Ag Fluorene und Carbazole als Liganden des EP2 Rezeptors
JP5247675B2 (ja) * 2006-03-24 2013-07-24 チルドレンズ メディカル センター コーポレーション 造血性幹細胞の増殖を調節する方法
CN101517070A (zh) * 2006-05-31 2009-08-26 Styx有限责任公司 选择干细胞的方法及其用途
CN101506353A (zh) * 2006-06-15 2009-08-12 尼奥斯泰姆公司 外周造血干细胞的处理方法
US20110165128A1 (en) * 2008-03-07 2011-07-07 Columbia University In The City Of New York Homing in mesenchymal stem cells
ES2845641T3 (es) * 2008-11-06 2021-07-27 Univ Indiana Res & Tech Corp Materiales y métodos para mejorar procedimientos de injerto funcionante de células madre hematopoyéticas
JP5705127B2 (ja) * 2008-12-03 2015-04-22 アモーサイト インコーポレイテッド 梗塞領域灌流改善組成物および血管損傷修復の方法
JP2010193879A (ja) * 2009-01-27 2010-09-09 Jms Co Ltd 臍帯血造血幹細胞の増殖制御方法およびその用途
BR112013003366A2 (pt) * 2010-08-12 2020-08-04 Fate Therapeutics, Inc. terapia aperfeiçoada de células tronco hematopoiéticas e progenitoras

Similar Documents

Publication Publication Date Title
JP2018184448A5 (cg-RX-API-DMAC7.html)
Kelly et al. Ex vivo expansion of cord blood
ES2627043T3 (es) Aumento de la eficacia de la terapia celular incluyendo tratamiento con alfa 1-3 fucoslitransferasa
Fajardo-Orduña et al. Hematopoietic support capacity of mesenchymal stem cells: biology and clinical potential
Haider et al. Bone marrow stem cell transplantation for cardiac repair
Malgieri et al. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art
Zhong et al. Feasibility investigation of allogeneic endometrial regenerative cells
Sieveking et al. Cell therapies for therapeutic angiogenesis: back to the bench
Tung et al. Ex vivo expansion of umbilical cord blood for transplantation
US9193953B2 (en) Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells
JP2013540105A5 (cg-RX-API-DMAC7.html)
US12006513B2 (en) Methods for the long-term expansion of granulocyte-macrophage progenitors and applications thereof
RU2015134394A (ru) Перепрограммирование эндотелия человека в гемопоэтических предшественников множественных линий дифференцировки с использованием определенных факторов
Oh et al. Stem cell and exosome therapy in pulmonary hypertension
JP2024016037A5 (cg-RX-API-DMAC7.html)
US8440460B2 (en) Methods for transdifferentiating cells
Wang et al. Allogeneic stem cell transplantation combined with transfusion of mesenchymal stem cells in primary myelofibrosis: a multicenter retrospective study
Kim et al. Cell therapy with bone marrow cells for myocardial regeneration
Quesenberry et al. The new stem cell biology
Turksen Stem cells: Current challenges and new directions
Aanei et al. Evaluation of bone marrow microenvironment could change how myelodysplastic syndromes are diagnosed and treated
Cetrulo et al. Perinatal stem cells
Ren et al. Umbilical cord blood hematopoietic stem cell expansion ex vivo
Sergeevicheva et al. Autologous mesenchymal stromal cells of hemoblastosis patients efficiently support hematopoietic recovery after stem cell transplantation
Feng et al. Hypothesis: human umbilical cord blood-derived stromal cells promote megakaryocytopoiesis through the influence of SDF-1 and PECAM-1